Biogen Inc. (BIIB)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
308.17+1.32 (+0.43%)
At close: 4:00 PM EDT
People also watch:
CELGGILDREGNAMGNALXN
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Open307.21
Prev Close306.85
Bid295.00 x 200
Ask308.17 x 100
Day's Range304.56 - 310.56
52wk Range223.02 - 333.65
1y Target EstN/A
Market Cap67.53B
P/E Ratio (ttm)18.00
Beta0.43
Volume1,034,410
Avg Vol (3m)2,103,628
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • Forbes3 days ago

    Mad About Epipen? Here Are Some Ideas To Actually Fix America's Drug Pricing Mess

    Heather Bresch, chief executive officer of Mylan NV. Photographer: Chris Goodney/Bloomberg *** Local Caption *** Heather Bresch Mylan Pharmaceuticals has been raising the price of the EpiPen for six years. The world has been outraged about it for six days. Here, then, are some thoughts on turning the rage into change. “The

  • Allergan, Humana, Biogen: Billionaires’ Favorite Healthcare Stocks For Q3
    Insider Monkey4 days ago

    Allergan, Humana, Biogen: Billionaires’ Favorite Healthcare Stocks For Q3

    The healthcare sector had one of its worst years in almost a decade last year when several big names from the space saw their stocks plunge dramatically. The beginning of 2016 was equally dismal for several healthcare stocks, but they have managed to recoup some of the losses they suffered last year over the past […]

  • 24/7 Wall St.4 days ago

    Short Sellers Increase Bets in Major Biotechs

    The August 15 short interest data have been compared with the previous report, and short interest moves were mixed across these selected biotech stocks.